# A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

> **NCT05282914** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 41 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** administration of UI058
- **DRUG:** administration of UIC202004

## Key facts

- **NCT ID:** NCT05282914
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2021-04-14
- **Final completion:** 2021-09-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282914, "A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05282914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*